Rates of Pheochromocytoma/Paraganglioma Screening in at-Risk Populations.
Seda GrigoryanWinnie NhanLei ZhangCaitlin UrbanLili ZhaoAdina F TurcuPublished in: The Journal of clinical endocrinology and metabolism (2022)
PPGL screening is pursued in roughly half of patients with adrenal nodules and hypertension, but rarely in patients with treatment-resistant or early-onset hypertension. Like for other forms of secondary hypertension, PPGL screening occurs more often after serious complications develop.